Literature DB >> 14578266

Sirolimus-induced interstitial pneumonitis in an islet transplant recipient.

Benigno J Digon, Kristina I Rother, Boaz Hirshberg, David M Harlan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14578266     DOI： 10.2337/diacare.26.11.3191

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

1.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  Transdisciplinary approach to restore pancreatic islet function.

Authors:  Carmen Fotino; R Damaris Molano; Camillo Ricordi; Antonello Pileggi
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade.

Authors:  J E Blau; M R Abegg; W A Flegel; X Zhao; D M Harlan; K I Rother
Journal:  Am J Transplant       Date:  2015-07-16       Impact factor: 8.086

Review 4.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 5.  Benefit-risk assessment of sirolimus in renal transplantation.

Authors:  Dirk R J Kuypers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Risks and side effects of islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; A M James Shapiro
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

Review 7.  History of islet transplantation.

Authors:  Benigno J Digon
Journal:  Curr Diab Rep       Date:  2009-08       Impact factor: 4.810

8.  Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.

Authors:  E H Liu; B J Digon; B Hirshberg; R Chang; B J Wood; Z Neeman; A Kam; R A Wesley; S M Polly; R M Hofmann; K I Rother; D M Harlan
Journal:  Diabetologia       Date:  2009-05-06       Impact factor: 10.122

9.  Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.

Authors:  Michael R Rickels; Chengyang Liu; Richard D Shlansky-Goldberg; Scott A Soleimanpour; Kumar Vivek; Malek Kamoun; Zaw Min; Eileen Markmann; Maral Palangian; Cornelia Dalton-Bakes; Carissa Fuller; Allen J Chiou; Clyde F Barker; Eline T Luning Prak; Ali Naji
Journal:  Diabetes       Date:  2013-04-29       Impact factor: 9.461
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.